BioCentury
ARTICLE | Clinical News

Amevive alefacept: Additional Phase II data

November 21, 2005 8:00 AM UTC

Additional data from an international Phase II trial in 185 patients showed that Amevive plus methotrexate (MTX) led to significant improvement in disease and lowered disease progression vs. placebo p...